VA-CTA
29.11.2016 21:15:38 CET | Business Wire | Press release
The Consumer Technology Association (CTA)™ Foundation , a national foundation with the mission to link seniors and people with disabilities with technologies to enhance their lives, is proud to announce the winners of the second annual Eureka Park Accessibility Contest: ActiveProtective , Aira , Bansen Labs , BLITAB and KinTrans . The CTA Foundation partnered with Extreme Tech Challenge to collect entries from over 300 startups from around the world. Each winner will receive a booth in Eureka Park during CES® 2017 and a $2,500 cash prize. CES, the gathering place for the global technology industry, runs Jan. 5-8, 2017 in Las Vegas, NV.
“We look forward to witnessing new technologies that provide tools for seniors and people with disabilities, as well as their caregivers, that enable more healthy and independent lives,” said Stephen Ewell, executive director of the CTA Foundation. “Accessibility technology is truly changing lives for the better and will be front and center at CES 2017.”
The winners of the CTA Foundation contest were selected among emerging Eureka Park eligible startups for their innovations that have the potential for a positive impact on older adults and people with disabilities:
- ActiveProtective: Wearable belt that deploys an airbag when a fall is detected to help prevent hip fractures in older adults.
- Aira: Platform that connects blind and low vision individuals with certified virtual agents through wearable devices to assist navigation in everyday life.
- Bansen Labs: First universal adapter that enables individuals to connect their assistive devices to their favorite technologies.
- BLITAB: The world’s first tactile braille tablet that can display an entire page at once without any mechanical elements.
- KinTrans: Sign language translation software designed to provide effective communication between sign language users and those who use spoken language.
The Accessibility Marketplace is the premier marketplace to see how accessible technology is providing tools for individuals with disabilities to live healthy and independent lives. Building on last year’s successful inauguration, the marketplace will see a 50 percent increase in the number of exhibiting companies and return to the 2nd level of the Sands Expo Center in Tech West.
This year’s honorees in the Accessible Tech category of the Innovation Awards - an annual competition honoring outstanding design and engineering in consumer technology products - include Aipoly Vision , Open Sesame! , ReSound ENZO2 , Segina Cellion and 3dRudder . Additionally, there will be two CTA Foundation sponsored conference tracks focused on Accessibility, including Why Accessibility Matters to Tech Leaders and Autonomous Vehicles will Aid Independent Living .
To learn more about the CTA Foundation visit www.CTAFoundation.tech .
Note to Editors: The official name of the global technology event is “CES ® .” Please do not use “Consumer Electronics Show” or “International CES” to refer to the event.
Please note updated CES security measures on CES.tech , including bag check points, bag restrictions and exceptions and badge pickup locations for CES 2017.
About the Consumer Technology Association (CTA) Foundation
The CTA Foundation, a public, national foundation affiliated with the Consumer Technology Association (CTA)™, was launched in 2012 with the mission to link seniors and people with disabilities with technologies to enhance their lives. The foundation strategically supports programs that affect these communities and facilitates dialog between industry, consumers, government, advocacy groups and other key stakeholders. For more information visit CTAFoundation.tech
About Consumer Technology Association:
Consumer Technology Association (CTA)TM , is the trade association representing the $287 billion U.S. consumer technology industry. More than 2,200 companies – 80 percent are small businesses and startups; others are among the world’s best known brands – enjoy the benefits of CTA membership including policy advocacy, market research, technical education, industry promotion, standards development and the fostering of business and strategic relationships. The Consumer Technology Association also owns and produces CES® – the world’s gathering place for all who thrive on the business of consumer technologies. Profits from CES are reinvested into CTA’s industry services.
About CES:
CES is the world’s gathering place for all who thrive on the business of consumer technologies. It has served as the proving ground for innovators and breakthrough technologies for 50 years—the global stage where next-generation innovations are introduced to the marketplace. As the largest hands-on event of its kind, CES features all aspects of the industry. Owned and produced by the Consumer Technology Association (CTA)TM , it attracts the world’s business leaders and pioneering thinkers. Check out CES video highlights . Follow CES online at CES.tech and on social .
UPCOMING EVENTS
-
CES Unveiled Las Vegas
January 3, Las Vegas, NV
-
CES 2017 –
Register
January 5-8, Las Vegas, NV
-
Winter Break
March 9-12, Snowmass, CO
-
CES Asia 2017
June 7-9, Shanghai, China
-
CEO Summit
June 21-24, Amalfi Coast, Italy
View source version on businesswire.com: http://www.businesswire.com/news/home/20161129006238/en/
Contact:
Consumer Technology Association
Danielle Cassagnol,
703-907-5253
dcassagnol@CTA.tech
www.CTA.tech
or
Elliot
Grimm, 703-907-5240
egrimm@CTA.tech
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
